Oltra, Javier
Campabadal, Anna
Segura, Barbara
Uribe, Carme
Marti, Maria Jose
Compta, Yaroslau
Valldeoriola, Francesc
Bargallo, Nuria
Iranzo, Alex
Junque, Carme
Funding for this research was provided by:
Ministerio de Ciencia, Innovación y Universidades (PRE2018-086675)
Horizon 2020 Framework Programme (Marie Sklodowska-Curie fellowship [grant agreement 888692], FIS/FEDER, H2020 programm)
Article History
Received: 1 June 2021
Accepted: 9 December 2021
First Online: 21 December 2021
Competing interests
: MJM received honoraria for advice and lecture from Abbvie, Bial and Merzt Pharma and grants from Michael J. Fox Foundation for Parkinson Disease (MJFF): MJF_PPMI_10_001, PI044024. YC has received funding in the past five years from Union Chimique Belge (UCB pharma), Teva, Medtronic, Abbvie, Novartis, Merz, Piramal Imaging, and Esteve, Bial, and Zambon. YC is currently an associate editor for Parkinsonism and Related Disorders. JO, AC, BS, CU, FV, NB, AI and CJ declare no potential conflict of interest.